eISSN 2287-9803 
pISSN 2287-9412 
Aims and Scope
Ethical Guidelines
Editoral Board
Forthcomming Issue
Current Issue
Most Read Articles
Informaion for Authors
Check List
Contact us
Review Article
  |   Neonatal Med_24_3_101_109.pdf
Neonatal Med August;24(3):101-109.
Published online 2017 August 31
Copyright ⓒ 2017 Neonatal Medicine Neonatal Medicine
Clinical Trials for Preterm Infants’ Neurodevelopment to the Norm: Erythropoietin and Nutritional Interventions
Sook-Hyun Park, M.D.
Department of Pediatrics, Kyungpook National University School of Medicine, Daegu, Korea
Corresponding Author: Sook-Hyun Park , Tel: +82-53-200-2812  , Fax: +82-53-425-6683  , Email: park_sh@knu.ac.kr
Although the incidence of severe intraventicular hemorrhage and cystic periventricular leukomalacia in preterm infants has significantly decreased, approximately 10–15% of preterm survivors demonstrate cerebral palsy and 50–80% of extremely preterm infants demonstrate mild-to-severe neurodevelopmental impairment. Compared to term infants, preterm infants show a higher incidence of brain damage secondary to hypoxic injury, inflammation, and malnutrition. Clinical trials have evaluated outcomes following early administration of high dose erythropoietin and nutritional interventions including early aggressive nutrition, human breast milk, and long-chain polyunsaturated fatty acids supplementation to prevent preterm infants’ neurodevelopmental impairment and improve neurodevelopmental outcome. Further studies are warranted to investigate the safety, optimal dose, timing, duration with respect to erythropoietin and nutritional interventions, and the optimization of a target population of preterm infants suited for interventions.
Keywords: Erythropoietin, Nutrition, Long-chain polyunsaturated fatty acids, Preterm infants
Copyright(c) By Korean Society of Neonatology. All right reserved.
Rm.1207, King's garden 3 Block, 34, Sajik-ro 8-gil, Jongno-gu, Seoul 110-872, Korea. TEL: +82-2-730-1993 FAX: +82-2-730-1994 Email:neonate2002@hanmail.net